Onkologie. 2013:7(1):47-50

Natural compounds and their anticancer potential

Pavel Klener1, Pavel Klener jr.1,2
1 1. interní klinika VFN a 1. LF UK v Praze
2 Ústav patologické fyziologie 1. LF UK v Praha

Plant derived compounds have been an important source of many clinically useful anti-cancer agents. These include drugs acting as

conventional cytostatics, such as microtubule modifiers (vincristin, vinblastin, taxanes), or topoisomerase inhibitors, such as epipodophyllotoxin

and camptothecin derivatives (etoposid, irinotecan). From plant or marine organisms derived also drugs against cancer-related

molecular targets (flavopiridol, combrestatin etc.), which are under clinical or preclinical development. Numerous phytochemicals

derived from edible plants have been reported to interfere with a specific stage of the carcinogenic process. These chemopreventive

phytochemicals are shortly reviewed.

Keywords: vinca alkaloids, epipodophyllotoxins, camptothecins, cell cycle specific inhibitors, chemopreventive substances

Published: February 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klener P, Klener P. Natural compounds and their anticancer potential. Onkologie. 2013;7(1):47-50.
Download citation

References

  1. Wachtel-Galor S, Bentie IFF. Herbal medicine An introduction to its history, usage, regulation, current trends, and research needs. in: Bentie IFF, Wachtel-Galor S (Eds). BocaRaton, CRC Press, Philadelphia 2011.
  2. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci 2005; 78: 431-441. Go to original source... Go to PubMed...
  3. Patel B, Sattwik D, Prakash R. Natural bioactive compound with anticancer potential. Int J Adv. Pahrm Sciences 2010; 1: 32-34. Go to original source...
  4. Pandey G, Madhuri S. Some medicinal plants as natural anticancer agents. Phcog Rev. 2009; 3: 259-263.
  5. Amin A, Gali-Muhtasib H, Ocker M, et al. A review of major classes of plant-derived anticancer drugs. Int J Biomed Sci 2009; 5: 1-11.
  6. Klener P. Vinca alkaloid. Experimental and clinical trials. Acta Univ.Carol. Monographia LVIII, Praha 1974: 157.
  7. Klener P, Klener P, jr. Nová protinádorová léčiva a léčebné strategie v onkologii. Grada Publishing. Praha 2010: 209.
  8. Dumontet C. Antitubulin agents. Bull Cancer 2011; 11: 1275-1285. Go to original source... Go to PubMed...
  9. Robová H. Topotecan. Remedia 2008; 8: 402-406.
  10. Gordaliza M, Castro MA delCoral JM, et al. Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Des 2000; 76: 1811-1839. Go to original source... Go to PubMed...
  11. Schofski P, Wolter P, Clement P, et al. Trabectedin (ET 743) for chemotherapy-naive patients with advanced soft tissue sarcomas: Multi-center phase II and pharmacokinetic study. J Clin Oncol 2007; 23: 5484-5492. Go to original source...
  12. Sithranga N, Kathiresan K. Anticancer drugs from marine flora: An overview. J Oncol. 2010; 214: 186-196. Go to original source... Go to PubMed...
  13. Ahmad I, Al Katib AM, Beck FE, et al. Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosin. Clin Cancer Res 2000; 6: 1328-1332.
  14. Zhai S, Senderowicz AM, Sausville EA, et al. Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development. Ann Pharmacother 2002; 35: 905-911. Go to original source... Go to PubMed...
  15. Xie J, Ting M, Gu Y, et al. Berbamine derivatives: A novel class of compounds for anti-leukemia activity. Eur. J. Med Chem 2009; 44: 3293-3296. Go to original source... Go to PubMed...
  16. Nam S, Xie J, Perkins A, et al. Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human myeloma cells. Molecul Oncol 2012 in press. Go to original source... Go to PubMed...
  17. Li HQ, Luo Y, Qiao CH. The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone. Mini Rev Med Chem 2012; 12: 350-362. Go to original source... Go to PubMed...
  18. Schwartsmann G, Brondani da Rocha A, Berlinsk R, et al. Marine organisms as a source of new anticancer agents. The Lancet Oncol 2001; 2: 221-225. Go to original source... Go to PubMed...
  19. Broggini M, Marchini SV, Galliera E, et al. Applidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (Flt-1) autocrine loop in human leukemia cell line MOLT 4. Leukemia 2003; 17: 52-59. Go to original source... Go to PubMed...
  20. LeTourneau C, Sandrine F, Ciruelos E, et al. Reports od clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinoma. Amer J Clin Oncol 2010; 33: 132-136. Go to original source...
  21. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780. Go to original source... Go to PubMed...
  22. Gullet NP, Ruhul Amin AR, Bayraktar S, et al. Cancer prevention with natural compounds. SeminOncol 2010; 37: 258-281. Go to original source... Go to PubMed...
  23. Aziz MH, Kumar R, Ahmad N. Cancer prevention with resveratrol. Int J Oncol 2003; 23: 17-28.
  24. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780. Go to original source... Go to PubMed...
  25. Tsao AS, Kim ES, KiHong W. Chemoprevention of cancer. CA Cancer J Clin 2004; 54: 150-180. Go to original source... Go to PubMed...
  26. Arit VM, Stiborova N, Schmeiser HH. Aristocholic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002; 17: 265-277. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.